Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out
March20 podcast Dr Hazen
anti-TMA pill in a year or 2 ? (scroll 12 mins)

Additional info:
MEBO Karen
at UK Findacure conf 2020

Scroll down and select country

MEBO Map Testing & Meetups

Full details :
want listed ? contact

MEBO - UBIOME study 2018



MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person


Participation info : LINK English

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts



TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned

Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
NORD Member Organization
See RareConnect

Popular Posts (last 30 days)

Upcoming get-togethers

Let us know if you want a meetup listed

Subscribe to Blog

Enter your email address:

Delivered by FeedBurner

You will be sent a verification email

Subscribe in a reader

Blog Archive

MEBO Research Clinical Trials

Click here to read details of the MEBO Clinical Trials
NCT03582826 - Ongoing not recruiting
Microbial Basis of Systemic Malodor and PATM Conditions (PATM)
United States 2018 - ongoing

NCT02683876 - Completed
Exploratory Study of Relationships Between Malodor and Urine Metabolomics
Canada and United States 2016 - ongoing

NCT03451994 - Completed
Exploratory Study of Volatile Organic Compounds in Alveolar Breath
United Kingdom and United States 2013 - ongoing

NCT02692495 - Completed
Evaluation of Potential Screening Tools for Metabolic Body Odor and Halitosis
United Kingdom 2009 - 2012

Saturday, January 31, 2009

Some extracts on FMO enzymes in books via googlebooks

The Flavin Mono-oxygenase 3 enzyme is said to be flawed in a diagnosis of Primary Trimethylaminuria (despite anecdotal test results of DNA suggesting otherwise, and also a dissertation where 8/12 had no mutants/variants). The enzyme deals with a lot of odorous substrates; sulfides and amines and phosphorus compounds. As textbooks currently say, since these other compounds are thought to be able to go a slower complex alternative route, via the P450 enzymes, (P450 and FMO are regarded as a layer of oxidizing activating/detoxing enzymes - the phase 1 enzymes) the other sulfides and amines aren't regarded as un-oxidizable as trimethylamine is. Perhaps this enzyme will turn out to be the main 'smelly' enzyme and perhaps the problem is to do with a backlog of these substrates. Trimethylamine doesn't seem to explain fecal body odor, whereas other sulfides and amines seem plausible.

For this reason, it is probabably useful to know about these enzymes, and in particular, FMO3. This is a good extract from a 2003 Molecular Toxicology book about the FMO family of enzymes.

Molecular Toxicology By Nick Plant: FMO

This chapter is from a 'gold standard' 2001 medical book on toxicology, the chapter dealing with the xenobiotic metabolizing enzymes (aka drug metabolizing enzymes, first pass enzymes, phase1/phase2 enzymes).

Casarett and Doull's Toxicology: Biotransformation of xenobiotics


Post a Comment